Thursday, April 27, 2017 5:55:53 PM
the studies include: the ability of 5T4 CAR-T cells to kill
a wide range of 5T4-expressing tumour cell lines in vitro;
the ability of T cells taken from patients with ovarian
cancer to be re-programmed with the 5T4 CAR construct
and respond functionally to their own tumour cells
in vitro through the secretion of cytokines; and the ability
of 5T4 CAR-T cells to control tumour cell growth in
in vivo models. Further data will be presented in due
course either at a conference or in a publication.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM